Literature DB >> 19762545

Functional screening of FxxLF-like peptide motifs identifies SMARCD1/BAF60a as an androgen receptor cofactor that modulates TMPRSS2 expression.

Dennis J van de Wijngaart1, Hendrikus J Dubbink, Michel Molier, Carola de Vos, Jan Trapman, Guido Jenster.   

Abstract

Androgen receptor (AR) transcriptional activity is tightly regulated by interacting cofactors and cofactor complexes. The best described cofactor interaction site in the AR is the hormone-induced coactivator binding groove in the ligand-binding domain, which serves as a high-affinity docking site for FxxLF-like motifs. This study aimed at identifying novel AR cofactors by in silico selection and functional screening of FxxLF-like peptide motifs. Candidate interacting motifs were selected from a proteome-wide screening and from a supervised screening focusing on components of protein complexes involved in transcriptional regulation. Of the 104 peptides tested, 12 displayed moderate to strong in vivo hormone-dependent interactions with AR. For three of these, ZBTB16/PLZF, SMARCA4/BRG1, and SMARCD1/BAF60a, the full-length protein was tested for interaction with AR. Of these, BAF60a, a subunit of the SWI/SNF chromatin remodeling complex, displayed hormone-dependent interactions with AR through its FxxFF motif. Vice versa, recruitment of BAF60a by the AR required an intact coactivator groove. BAF60a depletion by small interfering RNA in LNCaP cells demonstrated differential effects on expression of endogenous AR target genes. AR-driven expression of TMPRSS2 was almost completely blocked by BAF60a small interfering RNA. In summary, our data demonstrate that BAF60a directly interacts with the coactivator groove in the AR ligand-binding domain via its FxxFF motif, thereby selectively activating specific AR-driven promoters.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19762545      PMCID: PMC5419170          DOI: 10.1210/me.2008-0280

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  69 in total

1.  Development of peptide antagonists that target estrogen receptor beta-coactivator interactions.

Authors:  J M Hall; C Y Chang; D P McDonnell
Journal:  Mol Endocrinol       Date:  2000-12

Review 2.  The roles of protein-protein interactions and protein methylation in transcriptional activation by nuclear receptors and their coactivators.

Authors:  Michael R Stallcup; Jeong Hoon Kim; Catherine Teyssier; Young-Ho Lee; Han Ma; Dagang Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2003-06       Impact factor: 4.292

3.  ATP-driven chromatin remodeling activity and histone acetyltransferases act sequentially during transactivation by RAR/RXR In vitro.

Authors:  F J Dilworth; C Fromental-Ramain; K Yamamoto; P Chambon
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

4.  Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter.

Authors:  K B Cleutjens; C C van Eekelen; H A van der Korput; A O Brinkmann; J Trapman
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

5.  FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor.

Authors:  B He; J A Kemppainen; E M Wilson
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

6.  Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex.

Authors:  Maggie C Louie; Hong Qiong Yang; Ai-Hong Ma; Wei Xu; June X Zou; Hsing-Jien Kung; Hong-Wu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-14       Impact factor: 11.205

7.  TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.

Authors:  Karin G Hermans; Ronald van Marion; Herman van Dekken; Guido Jenster; Wytske M van Weerden; Jan Trapman
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

8.  Gene structure of rat BAF60b, a component of mammalian SW1/SNF complexes, and its physical linkage to the growth hormone gene and transcription factor SUG/proteasome p45 gene.

Authors:  K Nomoto; S Nakazato; K Kazahari; M Ono
Journal:  Gene       Date:  1997-11-20       Impact factor: 3.688

9.  TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.

Authors:  Scott A Tomlins; Rohit Mehra; Daniel R Rhodes; Lisa R Smith; Diane Roulston; Beth E Helgeson; Xuhong Cao; John T Wei; Mark A Rubin; Rajal B Shah; Arul M Chinnaiyan
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

10.  A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression.

Authors:  Qianben Wang; Dipali Sharma; Yunsheng Ren; Joseph D Fondell
Journal:  J Biol Chem       Date:  2002-09-05       Impact factor: 5.157

View more
  13 in total

1.  Analysis of interdomain interactions of the androgen receptor.

Authors:  Elizabeth M Wilson
Journal:  Methods Mol Biol       Date:  2011

2.  miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation.

Authors:  Dandan Sun; Yong Sun Lee; Ankit Malhotra; Hak Kyun Kim; Mirela Matecic; Clive Evans; Roderick V Jensen; Christopher A Moskaluk; Anindya Dutta
Journal:  Cancer Res       Date:  2011-01-06       Impact factor: 12.701

3.  Epigenetic Coregulation of Androgen Receptor Signaling.

Authors:  Rayzel C Fernandes; Damien A Leach; Charlotte L Bevan
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 4.  Epigenomic regulation of oncogenesis by chromatin remodeling.

Authors:  R Kumar; D-Q Li; S Müller; S Knapp
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

5.  Molecular Dynamics Simulations Revealed the Regulation of Ligands to the Interactions between Androgen Receptor and Its Coactivator.

Authors:  Na Liu; Wenfang Zhou; Yue Guo; Junmei Wang; Weitao Fu; Huiyong Sun; Dan Li; Mojie Duan; Tingjun Hou
Journal:  J Chem Inf Model       Date:  2018-07-20       Impact factor: 4.956

6.  RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.

Authors:  John R Prensner; Shuang Zhao; Nicholas Erho; Matthew Schipper; Matthew K Iyer; Saravana M Dhanasekaran; Cristina Magi-Galluzzi; Rohit Mehra; Anirban Sahu; Javed Siddiqui; Elai Davicioni; Robert B Den; Adam P Dicker; R Jeffrey Karnes; John T Wei; Eric A Klein; Robert B Jenkins; Arul M Chinnaiyan; Felix Y Feng
Journal:  Lancet Oncol       Date:  2014-11-17       Impact factor: 41.316

7.  BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression.

Authors:  Aktan Alpsoy; Sagar M Utturkar; Benjamin C Carter; Alisha Dhiman; Sandra E Torregrosa-Allen; Melanie P Currie; Bennett D Elzey; Emily C Dykhuizen
Journal:  Cancer Res       Date:  2020-12-21       Impact factor: 13.312

Review 8.  Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases.

Authors:  Ana Maria Olivares; Oscar Andrés Moreno-Ramos; Neena B Haider
Journal:  J Exp Neurosci       Date:  2016-05-05

9.  Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status.

Authors:  Caterina Mancarella; Irene Casanova-Salas; Ana Calatrava; Maria García-Flores; Cecilia Garofalo; Andrea Grilli; José Rubio-Briones; Katia Scotlandi; José Antonio López-Guerrero
Journal:  BMC Cancer       Date:  2017-05-25       Impact factor: 4.430

Review 10.  BRM: the core ATPase subunit of SWI/SNF chromatin-remodelling complex-a tumour suppressor or tumour-promoting factor?

Authors:  Iga Jancewicz; Janusz A Siedlecki; Tomasz J Sarnowski; Elzbieta Sarnowska
Journal:  Epigenetics Chromatin       Date:  2019-11-13       Impact factor: 4.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.